These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17303177)

  • 21. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
    Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
    Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
    Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M
    Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and enrichment of human genomic CpG islands by methylation-sensitive mirror orientation selection.
    Huang Q; Baum L; Huang JF; You JP; Wang F; Wang J; Zheng J; Yan XC; Xia H; Zhao YH; Kuang H; Fu WL
    Anal Biochem; 2007 Jun; 365(2):153-64. PubMed ID: 17481566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.
    Ulazzi L; Sabbioni S; Miotto E; Veronese A; Angusti A; Gafà R; Manfredini S; Farinati F; Sasaki T; Lanza G; Negrini M
    Mol Cancer; 2007 Feb; 6():17. PubMed ID: 17328794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
    Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
    Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.
    Ikeda JI; Morii E; Kimura H; Tomita Y; Takakuwa T; Hasegawa JI; Kim YK; Miyoshi Y; Noguchi S; Nishida T; Aozasa K
    J Pathol; 2006 Sep; 210(1):75-84. PubMed ID: 16823897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
    Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
    Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
    Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
    Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression and methylation status of 14-3-3sigma in human renal carcinoma tissues.
    Liang S; Xu Y; Shen G; Zhao X; Zhou J; Li X; Gong F; Ling B; Fang L; Huang C; Wei Y
    IUBMB Life; 2008 Aug; 60(8):534-40. PubMed ID: 18548556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
    Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
    Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells.
    Bhatia K; Siraj AK; Hussain A; Bu R; Gutiérrez MI
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):165-9. PubMed ID: 12582028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does aberrant DNA methylation occur in human uterine leiomyomas? An attempt of genome-wide screening by MS-RDA.
    Cai LY; Izumi S; Abe M; Imura M; Yasugi T; Wakazono K; Ohnuki Y; Kondo A; Ushijima T
    Tokai J Exp Clin Med; 2011 Sep; 36(3):84-90. PubMed ID: 21932190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
    Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
    Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.